Sanjay Sharma takes on additional responsibilities as CHRO at Dr Reddy’s

Dr Reddy’s Laboratories Ltd has announced that Sanjay Sharma, currently Global Head of Operations and a member of the company’s senior management, has been entrusted with additional responsibilities pertaining to the CHRO’s office, effective 1 December 2025.

The move follows the resignation of Archana Bhaskar, who will step down as Chief Human Resources Officer on 30 November 2025, the company said in a filing to the stock exchanges.

The Hyderabad-based pharmaceutical company said the change is part of a planned leadership transition and that Sharma will oversee HR responsibilities alongside his existing role. The decision was approved by the Board of Directors on 24 October 2025, following a recommendation from the Nomination, Governance and Compensation Committee.

A transformational leader with over three decades of experience across FMCG and pharmaceuticals, Sharma has held diverse roles spanning manufacturing, supply chain, sales, ESG and business transformation in both emerging and developed markets.

The leadership update coincided with the company’s second-quarter FY26 results, where Dr Reddy’s reported a 7 per cent year-on-year rise in consolidated net profit to ₹1,347 crore, up from ₹1,255 crore a year earlier, according to Business Standard. Revenue from operations grew 10 per cent to ₹8,828 crore, driven by branded markets and the Nicotine Replacement Therapy (NRT) portfolio, which offset a decline in US sales of Lenalidomide.

GV Prasad, Co-Chairman and Managing Director, said the quarter’s growth was driven by branded markets and the NRT portfolio, adding that the company remains focused on strengthening its core business and advancing its pipeline.

Dr Reddy’s shares closed 0.32 per cent higher at ₹1,284 on the BSE before the announcement. The company continues to invest in research, digital capabilities and workforce development — areas where Sharma’s expanded role is expected to further align talent strategy with business growth.